866-997-4948(US-Canada Toll Free)

United States Antidiabetic Drugs Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the United States Antidiabetic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antidiabetic Drugs in these regions, from 2012 to 2022 (forecast).

United States Antidiabetic Drugs market competition by top manufacturers/players, with Antidiabetic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Eli Lilly
Novartis
Boehringer Ingelheim
Merck
Novo Nordisk
Sanofi
AstraZeneca
Takeda
Bayer
Pfizer

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral Drugs
Injectable Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antidiabetic Drugs for each application, including
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes Mellitus
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Antidiabetic Drugs Market Report 2017
1 Antidiabetic Drugs Overview
1.1 Product Overview and Scope of Antidiabetic Drugs
1.2 Classification of Antidiabetic Drugs by Product Category
1.2.1 United States Antidiabetic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Antidiabetic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral Drugs
1.2.4 Injectable Drugs
1.3 United States Antidiabetic Drugs Market by Application/End Users
1.3.1 United States Antidiabetic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes Mellitus
1.3.5 Others
1.4 United States Antidiabetic Drugs Market by Region
1.4.1 United States Antidiabetic Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Antidiabetic Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Antidiabetic Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Antidiabetic Drugs Status and Prospect (2012-2022)
1.4.5 New England Antidiabetic Drugs Status and Prospect (2012-2022)
1.4.6 The South Antidiabetic Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Antidiabetic Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antidiabetic Drugs (2012-2022)
1.5.1 United States Antidiabetic Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Antidiabetic Drugs Revenue and Growth Rate (2012-2022)

2 United States Antidiabetic Drugs Market Competition by Players/Suppliers
2.1 United States Antidiabetic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antidiabetic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antidiabetic Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antidiabetic Drugs Market Competitive Situation and Trends
2.4.1 United States Antidiabetic Drugs Market Concentration Rate
2.4.2 United States Antidiabetic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antidiabetic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antidiabetic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Antidiabetic Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antidiabetic Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antidiabetic Drugs Price by Region (2012-2017)

4 United States Antidiabetic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Antidiabetic Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antidiabetic Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antidiabetic Drugs Price by Type (2012-2017)
4.4 United States Antidiabetic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Antidiabetic Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Antidiabetic Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Antidiabetic Drugs Players/Suppliers Profiles and Sales Data
6.1 Eli Lilly
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antidiabetic Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Eli Lilly Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Novartis
6.2.2 Antidiabetic Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
6.3.2 Antidiabetic Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Boehringer Ingelheim Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck
6.4.2 Antidiabetic Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novo Nordisk
6.5.2 Antidiabetic Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novo Nordisk Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi
6.6.2 Antidiabetic Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 AstraZeneca
6.7.2 Antidiabetic Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AstraZeneca Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Takeda
6.8.2 Antidiabetic Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Takeda Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.2 Antidiabetic Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Pfizer
6.10.2 Antidiabetic Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Pfizer Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Antidiabetic Drugs Manufacturing Cost Analysis
7.1 Antidiabetic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antidiabetic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antidiabetic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antidiabetic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Antidiabetic Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Antidiabetic Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antidiabetic Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antidiabetic Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antidiabetic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Antidiabetic Drugs
Figure United States Antidiabetic Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Antidiabetic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Drugs Product Picture
Figure Injectable Drugs Product Picture
Figure United States Antidiabetic Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antidiabetic Drugs by Application in 2016
Figure Type 1 Diabetes Examples
Table Key Downstream Customer in Type 1 Diabetes
Figure Type 2 Diabetes Examples
Table Key Downstream Customer in Type 2 Diabetes
Figure Gestational Diabetes Mellitus Examples
Table Key Downstream Customer in Gestational Diabetes Mellitus
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Antidiabetic Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidiabetic Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antidiabetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antidiabetic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antidiabetic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antidiabetic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidiabetic Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antidiabetic Drugs Sales Share by Players/Suppliers
Figure United States Antidiabetic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antidiabetic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antidiabetic Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antidiabetic Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antidiabetic Drugs Revenue Share by Players/Suppliers
Table United States Market Antidiabetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antidiabetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antidiabetic Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antidiabetic Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antidiabetic Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antidiabetic Drugs Product Category
Table United States Antidiabetic Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Antidiabetic Drugs Sales Share by Region (2012-2017)
Figure United States Antidiabetic Drugs Sales Share by Region (2012-2017)
Figure United States Antidiabetic Drugs Sales Market Share by Region in 2016
Table United States Antidiabetic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antidiabetic Drugs Revenue Share by Region (2012-2017)
Figure United States Antidiabetic Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antidiabetic Drugs Revenue Market Share by Region in 2016
Table United States Antidiabetic Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Antidiabetic Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Antidiabetic Drugs Sales Share by Type (2012-2017)
Figure United States Antidiabetic Drugs Sales Share by Type (2012-2017)
Figure United States Antidiabetic Drugs Sales Market Share by Type in 2016
Table United States Antidiabetic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antidiabetic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antidiabetic Drugs by Type (2012-2017)
Figure Revenue Market Share of Antidiabetic Drugs by Type in 2016
Table United States Antidiabetic Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Antidiabetic Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antidiabetic Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Antidiabetic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidiabetic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antidiabetic Drugs Sales Market Share by Application in 2016
Table United States Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Novartis Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Merck Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Merck Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novo Nordisk Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Novo Nordisk Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Novo Nordisk Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Takeda Basic Information List
Table Takeda Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Takeda Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Takeda Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Bayer Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antidiabetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antidiabetic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antidiabetic Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antidiabetic Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetic Drugs
Figure Manufacturing Process Analysis of Antidiabetic Drugs
Figure Antidiabetic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antidiabetic Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antidiabetic Drugs
Table Distributors/Traders List
Figure United States Antidiabetic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antidiabetic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antidiabetic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antidiabetic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antidiabetic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antidiabetic Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *